Physician profile
Ashley Wright
NPI 1740706811
$1,657.60
in general payments reported to CMS, 2019-2025
15 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $408 · 2023: $348 · 2024: $178 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,151.68 | 2021-2025 | Oasis, Stravix, Grafix Xc |
| Bsn Medical INC | $118.13 | 2023 | |
| Paratek Pharmaceuticals, INC. | $58.97 | 2023-2024 | Nuzyra |
| Abbvie INC. | $45.54 | 2022-2023 | |
| Urgo Medical North America, LLC | $41.79 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kci USA, INC. | $39.24 | 2021 | |
| Mimedx Group, INC. | $33.42 | 2025 | |
| Bioventus LLC | $31.19 | 2022-2023 | |
| Hartmann USA, INC. | $29.21 | 2021 | |
| Lifenet Health | $27.72 | 2024 | Theragenesis Wound Matrix |
| Exelixis INC. | $19.01 | 2025 | Cabometyx |
| Kerecis Limited | $17.79 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Reapplix INC. | $17.72 | 2025 | 3c Patch Kit - Box |
| Convatec INC. | $15.56 | 2021 | |
| Molnlycke Health Care US, LLC | $10.63 | 2025 | Mepilex Transfer Ag, Mepilex Ag, Exufiber Ag+ |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.